I'd say we have to "agree to disgree" but that would be
I'd say we have to "agree to disgree" but that would be like me agreeing to disagree because I think today is Friday and you think it's Monday. It IS Friday.
Empirical evidence is a defined term, and the formal labs, lab work, and regimen that CYDY is using makes their findings EMPIRICAL.
As Misiu stated, if NP's only evidence was "My mother in law is feeling better, went on a cruise, makes dinner, and just won the Boston Marathon, so therefore, Leronlimab must be working," that is anecdotal. You seem hung up on the number of patients before something changes from anecdotal to empirical, and that is not how it is defined.
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Top 5 Most Recently Viewed Articles
Blue Sky Hemp Ventures Shifts Focus to Cannabis Extracts Blue Sky Hemp Ventures Ltd. has strategically decided to sell its hemp-based food division to Fresh Hemp Foods. Founded in 2017, this innovative Canadian company has made a name for itself in the industrial hemp industry by emphasizing whole plant utilization. The recent sale, conducted for an undisclosed amount,...
Continue Reading
Introducing the Next Generation of Bathroom Hygiene CRYSTAL LAKE, Ill.-- Bio Bidet by Bemis, a leader in bidet design, has introduced its latest advancement: the BB-1200 Bidet Toilet Seat. This impressive product, honored with a 2024 CES Editors’ Choice award, stands out as North America’s first app-controlled bidet toilet seat, priced at an affordable $399. You can...
Continue Reading
Understanding the Skyworks Solutions, Inc. Class Action Skyworks Solutions, Inc. (NASDAQ: SWKS) has garnered attention from investors regarding recent developments in a class action lawsuit. This legal action stems from significant losses incurred by certain investors who purchased securities during a specified period, and now has become a focal point for those looking to...
Continue Reading
Ontario International Airport Sees Growth in Volumes Surge of international travel fueled passenger increase Passenger and cargo volumes at Ontario International Airport (ONT) have shown noteworthy growth this August, continuing a trend that shows both year-over-year increases in passenger numbers and consistent gains in cargo volumes. In August, the airport accommodated...
Continue Reading
Absci and AMD Form Strategic Partnership for AI Drug Discovery Absci Corporation (NASDAQ: ABSI), a leader in generative AI for drug development, has announced a significant collaboration with AMD, renowned for its innovations in high-performance computing. This partnership aims to accelerate advancements in AI drug discovery by deploying AMD Instinct™ accelerators and...
Continue Reading